Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 716-731
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.716
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.716
Variables | DM patients with regular insulin use | SMD | |||
Herb non-users, n = 140547 | Herb users, n = 46849 | ||||
n | % | n | % | ||
Sex | 0.014 | ||||
Female | 71872 | 51.14 | 24288 | 51.84 | |
Male | 68675 | 48.86 | 22561 | 48.16 | |
Age, yr | |||||
20-40 | 11623 | 8.27 | 4160 | 8.88 | 0.022 |
40-60 | 55239 | 39.30 | 18684 | 39.88 | 0.012 |
> 60 | 73685 | 52.43 | 24005 | 51.24 | 0.024 |
Mean (SD) | 59.47 (13.25) | 59.11 (13.38) | 0.027 | ||
Comorbidities | |||||
Hypertension | 107255 | 76.31 | 35223 | 75.18 | 0.026 |
Coronary heart disease | 60016 | 42.70 | 19862 | 42.40 | 0.006 |
Ischemic stroke | 32117 | 22.85 | 10366 | 22.13 | 0.017 |
Hemorrhagic stroke | 3418 | 2.43 | 1146 | 2.45 | 0.001 |
Hyperlipidemia | 114028 | 81.13 | 37707 | 80.49 | 0.016 |
Renal insufficiency | 24394 | 17.36 | 7823 | 16.70 | 0.018 |
Cirrhosis | 4952 | 3.52 | 1847 | 3.94 | 0.022 |
Alcoholic liver damage | 10313 | 7.34 | 3386 | 7.23 | 0.004 |
Nonalcoholic fatty liver disease | 12398 | 8.82 | 4178 | 8.92 | 0.003 |
HBV infection | 9560 | 6.80 | 3472 | 7.41 | 0.024 |
HCV infection | 5770 | 4.11 | 2107 | 4.50 | 0.019 |
Medication | |||||
Lipid-lowering drug | |||||
Statin | 8217 | 5.85 | 2766 | 5.90 | 0.003 |
Non-statin | 13990 | 9.95 | 4299 | 9.18 | 0.026 |
Aspirin | 4890 | 3.48 | 1559 | 3.33 | 0.008 |
HBV treatment | 1947 | 1.39 | 696 | 1.49 | 0.008 |
HCV treatment | 451 | 0.32 | 192 | 0.41 | 0.015 |
OAD | |||||
Biguanides | 9142 | 6.50 | 3054 | 6.52 | 0.001 |
Sulfonamide | 8855 | 6.30 | 2914 | 6.22 | 0.003 |
AGI | 22759 | 16.19 | 7829 | 16.71 | 0.014 |
Thiazolidinediones | 20022 | 14.25 | 7325 | 15.64 | 0.039 |
DPP4 inhibitors | 14313 | 10.18 | 5648 | 12.06 | 0.060 |
GLP-1 receptor agonist | 2982 | 2.12 | 1359 | 2.90 | 0.050 |
SGLT2 inhibitors | 8376 | 5.96 | 3639 | 7.77 | 0.072 |
Glinide | 25298 | 18.00 | 8886 | 18.97 | 0.025 |
Insulin dose (mg), mean (SD) | 9449.92 (135.59) | 8248.88 (115.34) | 0.071 |
- Citation: Lai HC, Cheng JC, Yip HT, Jeng LB, Huang ST. Chinese herbal medicine decreases incidence of hepatocellular carcinoma in diabetes mellitus patients with regular insulin management. World J Gastrointest Oncol 2024; 16(3): 716-731
- URL: https://www.wjgnet.com/1948-5204/full/v16/i3/716.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.716